VACCINE AND GENE THERAPY INSTITUTE… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

MICHAEL GOLDBERG

Phone

7723455645

Tax Period

2017-07-01 to 2018-06-30

VACCINE AND GENE THERAPY INSTITUTE OF FLORIDA CORP, founded in 2008, is a micro nonprofit in the Medical Research sector that reported $19 in total revenue in fiscal year 2017. Revenue fell 99% from the prior year — a significant decline worth monitoring. Expenses of $386K exceeded revenue, resulting in a 2031905% operating deficit.

Mission

THE MISSION OF THE VACCINE AND GENE THERAPY INSTITUTE OF FLORIDA (VGTI-FL) IS TO "TRANSLATE RESEARCH INTO HEALTH" BY PROVIDING A BETTER UNDERSTANDING OF THE HUMAN IMMUNE RESPONSE TO PATHOGENS AND CANCERS AND THE PROCESS OF AGING.

Program Service Accomplishments

Program 1

ON FEBRUARY 2, 2016, THE CIRCUIT COURT OF THE NINETEENTH JUDICIAL CIRCUIT, IN AND FOR ST. LUCIE COUNTY, FLORIDA ENTERED THE ORDER APPOINTING MICHAEL E. IMBER AS RECEIVER FOR VACCINE AND GENE THERAPY INSTITUTE FLORIDA CORPORATION (VGTI). ON MARCH 31, 2017, VGTI (ACTING THROUGH THE RECEIVER), THE CITY OF PORT SAINT LUCIE, FLORIDA (THE "CITY"), AND UMB BANK, NATIONAL ASSOCIATION, AS INDENTURE TRUSTEE ENTERED INTO A TRANSFER AGREEMENT PURSUANT TO WHICH VGTI AGREED TO TRANSFER ITS ASSETS TO THE CITY SUBJECT TO CERTAIN TERMS AND CONDITIONS. THAT TRANSFER OCCURRED ON AUGUST 11, 2017.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2017)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $19

Other Revenue $0

TOTAL REVENUE $19

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $386,081

TOTAL EXPENSES $386,081

Year-over-Year Comparison

	2017	2016	Change
Revenue	$19	$1,712	-1.0%
Expenses	$386,081	$1,964,588	-0.8%
Net Income	$-386,062	$-1,962,876	-0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHAEL GOLDBERG	RECEIVER	50.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2018	$19	$386,081	$217,466	$-386,062

VACCINE AND GENE THERAPY INSTITUTE OF FLORIDA CORP